Neurology:卒中后癫痫影响青年卒中患者长期功能预后

2013-12-03 佚名 丁香园

该研究的目的是研究青年卒中幸存者发生卒中后癫痫对长期功能预后的影响。 该研究为前瞻性队列研究,共纳入537例年龄在18到50岁间的卒中幸存者,其为首次发生的短暂性脑缺血发作、缺血性卒中和出血性卒中。在平均随访9.8年后,评价卒中后癫痫与功能预后的关系。使用logistic回归分析改良后Rankin评分(mRS评分大于2分)及日常活动评价工具评分(IADL小于8分)评价显示的不良预后优势比


该研究的目的是研究青年卒中幸存者发生卒中后癫痫对长期功能预后的影响。

该研究为前瞻性队列研究,共纳入537例年龄在18到50岁间的卒中幸存者,其为首次发生的短暂性脑缺血发作、缺血性卒中和出血性卒中。在平均随访9.8年后,评价卒中后癫痫与功能预后的关系。使用logistic回归分析改良后Rankin评分(mRS评分大于2分)及日常活动评价工具评分(IADL小于8分)评价显示的不良预后优势比。【原文下载】

在纳入的537例青年卒中幸存者中,有40例缺血性卒中患者,4例TIA患者,10例出血性卒中患者发生卒中后癫痫。发生癫痫的缺血性卒中患者通过改良Rankin评分和IADL评价显示其功能预后较差。而在TIA患者和出血性青年卒中患者中,其功能预后没有明显差别。多元回归分析显示卒中后癫痫为缺血性卒中不良预后的独立危险因素。相反,IADL评分却没显示出有相关性。

青年卒中患者发生卒中后癫痫为一种常见的临床问题,可影响卒中患者的功能预后,甚至在缺血性卒中发生10年后对预后仍有一定影响。

研究背景:

青年卒中,即发生在18到50岁间的卒中,病因多为动脉夹层分离、心源性栓塞、非动脉粥样硬化性血管病和高凝状态,而50岁以上的成人传统的动脉粥样硬化危险因素则是其主要原因。青年处于人生的黄金时期,正确的治疗青年人脑血管病,或能在亚临床阶段,及早去发现青年人脑血管病的危险因素,研究青年卒中的预后影响因素,尤为重要。

原文出处:

Arntz RM, Maaijwee NA, Rutten-Jacobs LC, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, de Leeuw FE.Epilepsy after TIA or stroke in young patients impairs long-term functional outcome: The FUTURE Study.Neurology. 2013 Nov 26;81(22):1907-13. doi: 10.1212/01.wnl.0000436619.25532.f3. 【原文下载】

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720010, encodeId=32901e20010d1, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 31 01:28:00 CST 2014, time=2014-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999355, encodeId=925f1999355f5, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 16 20:28:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671175, encodeId=4bac16e117536, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Mon May 26 03:28:00 CST 2014, time=2014-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770048, encodeId=2a531e7004856, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Mon Apr 07 10:28:00 CST 2014, time=2014-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492832, encodeId=62bf14928324f, content=<a href='/topic/show?id=447732948d0' target=_blank style='color:#2F92EE;'>#功能预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32948, encryptionId=447732948d0, topicName=功能预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=728c8977388, createdName=zsyan, createdTime=Thu Dec 05 01:28:00 CST 2013, time=2013-12-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720010, encodeId=32901e20010d1, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 31 01:28:00 CST 2014, time=2014-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999355, encodeId=925f1999355f5, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 16 20:28:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671175, encodeId=4bac16e117536, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Mon May 26 03:28:00 CST 2014, time=2014-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770048, encodeId=2a531e7004856, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Mon Apr 07 10:28:00 CST 2014, time=2014-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492832, encodeId=62bf14928324f, content=<a href='/topic/show?id=447732948d0' target=_blank style='color:#2F92EE;'>#功能预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32948, encryptionId=447732948d0, topicName=功能预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=728c8977388, createdName=zsyan, createdTime=Thu Dec 05 01:28:00 CST 2013, time=2013-12-05, status=1, ipAttribution=)]
    2014-05-16 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1720010, encodeId=32901e20010d1, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 31 01:28:00 CST 2014, time=2014-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999355, encodeId=925f1999355f5, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 16 20:28:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671175, encodeId=4bac16e117536, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Mon May 26 03:28:00 CST 2014, time=2014-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770048, encodeId=2a531e7004856, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Mon Apr 07 10:28:00 CST 2014, time=2014-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492832, encodeId=62bf14928324f, content=<a href='/topic/show?id=447732948d0' target=_blank style='color:#2F92EE;'>#功能预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32948, encryptionId=447732948d0, topicName=功能预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=728c8977388, createdName=zsyan, createdTime=Thu Dec 05 01:28:00 CST 2013, time=2013-12-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1720010, encodeId=32901e20010d1, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 31 01:28:00 CST 2014, time=2014-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999355, encodeId=925f1999355f5, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 16 20:28:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671175, encodeId=4bac16e117536, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Mon May 26 03:28:00 CST 2014, time=2014-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770048, encodeId=2a531e7004856, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Mon Apr 07 10:28:00 CST 2014, time=2014-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492832, encodeId=62bf14928324f, content=<a href='/topic/show?id=447732948d0' target=_blank style='color:#2F92EE;'>#功能预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32948, encryptionId=447732948d0, topicName=功能预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=728c8977388, createdName=zsyan, createdTime=Thu Dec 05 01:28:00 CST 2013, time=2013-12-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1720010, encodeId=32901e20010d1, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 31 01:28:00 CST 2014, time=2014-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999355, encodeId=925f1999355f5, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 16 20:28:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671175, encodeId=4bac16e117536, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Mon May 26 03:28:00 CST 2014, time=2014-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770048, encodeId=2a531e7004856, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Mon Apr 07 10:28:00 CST 2014, time=2014-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492832, encodeId=62bf14928324f, content=<a href='/topic/show?id=447732948d0' target=_blank style='color:#2F92EE;'>#功能预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32948, encryptionId=447732948d0, topicName=功能预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=728c8977388, createdName=zsyan, createdTime=Thu Dec 05 01:28:00 CST 2013, time=2013-12-05, status=1, ipAttribution=)]

相关资讯

Stroke:男性卒中患者静脉溶栓预后或较女性差

静脉组织型纤溶酶原激活剂(tPA)为治疗急性缺血性卒中的主要措施,但对于静脉溶栓的预后结果是否存在性别差异的研究结论并不一致,一些临床随机试验表明,女性从静脉rtPA受益更多,但一些研究却提示男性受益为女性的3倍。 针对这种情况,来自意大利罗马智慧大学的Lorenzano S等人进行了一项研究,我们的研究目的是评估使用静脉组织类型纤溶酶原激活物治疗急性缺血性脑卒中患者

Neurology:首次卒中急性期疲劳预示未来18个月患者生活质量更差

近期Neurology杂志一项研究表明急性期疲劳是卒中患者长期身体健康和生活质量较差的独立危险因素。研究强调,对急性期疲劳的诊疗可改善卒中幸存者的身体健康相关生活质量。该研究旨在明确卒中后急性期疲劳是否能预测18个月后患者身体和心理健康长期预后。其对首次卒中(急性期)患者(96例,平均年龄67.8岁)入院2周内及18个月后进行评估。评估方法包括疲劳严重程度量表和贝克抑郁量表II 。使用SF-36(

Eur Heart J:老年阵发性房颤患者诊断后5年内常死亡

美德学者联合进行的一项研究表明,年龄≥65岁的老年人在被诊断为阵发性心房颤动后的首个5年期间,死亡是最常见的主要转归;在非致命性心血管事件中,最常见的为心力衰竭。相关论文11月25日在线发表于《欧洲心脏杂志》(Eur Heart J)。 该基于人群的回顾性队列研究旨在探索新诊断房颤的老年人发生严重临床事件的风险因素。共纳入年龄≥65岁的近期无住院的186 4

日本研究发现女性饮酒增脑卒中

日本一个研究小组9月25日宣布,大规模调查发现,与偶尔饮酒的女性相比,每天饮酒量超过1瓶啤酒的女性,患脑卒中(俗称“脑中风”)的风险是前者的1.5至2倍。 此前有调查显示,大量饮酒会提高男性患脑卒中的风险。这是日本国内首次以女性为对象进行的有关调查。 日本大阪大学和日本国立癌症研究中心的研究小组以日本国内约4.7万名40至69岁的健康女性为对象,平均跟踪调查了1

Stroke:脑微出血或可作为卒中后抑郁的预测指标

脑微出血(CMBs)常见于卒中幸存者和社区居住的老年人,脑微出血预测卒中后抑郁(PSD)的结果的临床意义仍然未知,针对这种情况,来自香港中文大学精神卫生系的邓伟光教授等人进行了一项研究,研究结果在线发表在2013年10月31日的Stroke杂志上。这项研究目的在于评估脑微出血与卒中后抑郁1年结果两者之间的联系,研究表明脑叶部脑微出血也许会影响卒中后抑郁的结果。 这项研

AHA 2013:“虚拟现实手”可帮助卒中幸存者恢复手部功能

2013年美国心脏协会(AHA)科学年会发布的一项小型研究发现,由卒中幸存者思想所控制的“虚拟现实手”能帮助其恢复使用手臂。 研究者明尼苏达大学Alexander Doud介绍,采用脑-计算机接口可为存在身体障碍无法移动的患者创建一种练习有助于恢复手臂应用的心理意象环境。这种技术能确定患者能否以更好的方式激活大脑中相关区域以促进其恢复。康复过程中,通常治疗师会按所需方